Resource Hydroxyacetic Acid

Predicate	Value (sorted: default)
rdfs:label	"Hydroxyacetic Acid"
rdf:type	ns1:drugs
ns1:description	" 79-14-1 experimental David Y. Tang, Arthur M. Foster, "(3-Trifluoromethylphenyl)-alpha-hydroxyacetic acid and process for preparation." U.S. Patent US4296244, issued January, 1977. This compound belongs to the alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon. Alpha Hydroxy Acids and Derivatives Organic Compounds Organic Acids and Derivatives Hydroxy Acids and Derivatives Alpha Hydroxy Acids and Derivatives Primary Alcohols Polyamines Enolates Carboxylic Acids carboxylic acid derivative enolate carboxylic acid polyamine primary alcohol alcohol Hydroxyethanoic Acid Keratolytic Agents logP -1 ALOGPS logS 0.9 ALOGPS Water Solubility 6.08e+02 g/l ALOGPS logP -1 ChemAxon IUPAC Name 2-hydroxyacetic acid ChemAxon Traditional IUPAC Name hydroxyacetic acid ChemAxon Molecular Weight 76.0514 ChemAxon Monoisotopic Weight 76.016043994 ChemAxon SMILES OCC(O)=O ChemAxon Molecular Formula C2H4O3 ChemAxon InChI InChI=1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5) ChemAxon InChIKey InChIKey=AEMRFAOFKBGASW-UHFFFAOYSA-N ChemAxon Polar Surface Area (PSA) 57.53 ChemAxon Refractivity 14.35 ChemAxon Polarizability 6.2 ChemAxon Rotatable Bond Count 1 ChemAxon H Bond Acceptor Count 3 ChemAxon H Bond Donor Count 2 ChemAxon pKa (strongest acidic) 3.53 ChemAxon pKa (strongest basic) -3.6 ChemAxon Physiological Charge -1 ChemAxon Number of Rings 0 ChemAxon Bioavailability 1 ChemAxon Rule of Five true ChemAxon Melting Point 79.5 Â°C PhysProp logP -1.11 HANSCH,C ET AL. (1995) pKa 3.83 SERJEANT,EP & DEMPSEY,B (1979) ChEBI 29805 PubChem Compound 757 PubChem Substance 46508186 KEGG Compound C00160 PDB GOA BE0001089 Glucose-6-phosphate 1-dehydrogenase Human # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Glucose-6-phosphate 1-dehydrogenase Carbohydrate transport and metabolism Produces pentose sugars for nucleic acid synthesis and main producer of NADPH reducing power G6PD Xq28 None 6.84 59257.0 Human HUGO Gene Nomenclature Committee (HGNC) HGNC:4057 GenAtlas G6PD GeneCards G6PD GenBank Gene Database X03674 GenBank Protein Database 31543 UniProtKB P11413 UniProt Accession G6PD_HUMAN EC 1.1.1.49 G6PD >Glucose-6-phosphate 1-dehydrogenase MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGL LPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQR LNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSS DRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEP FGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGK ALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESEL DLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPI PYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL >1548 bp ATGGCAGAGCAGGTGGCCCTGAGCCGGACCCACGTGTGCGGGATCCTGCGGGAAGAGCTT TTCCAGGGCGATGCCTTCCATCAGTCGGATACACACATATTCATCATCATGGGTGCATCG GGTGACCTGGCCAAGAAGAAGATCTACCCCACCATCTGGTGGCTGTTCCGGGATGGCCTT CTGCCCGAAAACACCTTCATCGTGGGCTATGCCCGTTCCCGCCTCACAGTGGCTGACATC CGCAAACAGAGTGAGCCCTTCTTCAAGGCCACCCCAGAGGAGAAGCTCAAGCTGGAGGAC TTCTTTGCCCGCAACTCCTATGTGGCTGGCCAGTACGATGATGCAGCCTCCTACCAGCGC CTCAACAGCCACATGAATGCCCTCCACCTGGGGTCACAGGCCAACCGCCTCTTCTACCTG GCCTTGCCCCCGACCGTCTACGAGGCCGTCACCAAGAACATTCACGAGTCCTGCATGAGC CAGATAGGCTGGAACCGCATCATCGTGGAGAAGCCCTTCGGGAGGGACCTGCAGAGCTCT GACCGGCTGTCCAACCACATCTCCTCCCTGTTCCGTGAGGACCAGATCTACCGCATCGAC CACTACCTGGGCAAGGAGATGGTGCAGAACCTCATGGTGCTGAGATTTGCCAACAGGATC TTCGGCCCCATCTGGAACCGGGACAACATCGCCTGCGTTATCCTCACCTTCAAGGAGCCC TTTGGCACTGAGGGTCGCGGGGGCTATTTCGATGAATTTGGGATCATCCGGGACGTGATG CAGAACCACCTACTGCAGATGCTGTGTCTGGTGGCCATGGAGAAGCCCGCCTCCACCAAC TCAGATGACGTCCGTGATGAGAAGGTCAAGGTGTTGAAATGCATCTCAGAGGTGCAGGCC AACAATGTGGTCCTGGGCCAGTACGTGGGGAACCCCGATGGAGAGGGCGAGGCCACCAAA GGGTACCTGGACGACCCCACGGTGCCCCGCGGGTCCACCACCGCCACTTTTGCAGCCGTC GTCCTCTATGTGGAGAATGAGAGGTGGGATGGGGTGCCCTTCATCCTGCGCTGCGGCAAG GCCCTGAACGAGCGCAAGGCCGAGGTGAGGCTGCAGTTCCATGATGTGGCCGGCGACATC TTCCACCAGCAGTGCAAGCGCAACGAGCTGGTGATCCGCGTGCAGCCCAACGAGGCCGTG TACACCAAGATGATGACCAAGAAGCCGGGCATGTTCTTCAACCCCGAGGAGTCGGAGCTG GACCTGACCTACGGCAACAGATACAAGAACGTGAAGCTCCCTGACGCCTACGAGCGCCTC ATCCTGGACGTCTTCTGCGGGAGCCAGATGCACTTCGTGCGCAGCGACGAGCTCCGTGAG GCCTGGCGTATTTTCACCCCACTGCTGCACCAGATTGAGCTGGAGAAGCCCAAGCCCATC CCCTATATTTATGGCAGCCGAGGCCCCACGGAGGCAGACGAGCTGATGAAGAGAGTGGGT TTCCAGTATGAGGGCACCTACAAGTGGGTGAACCCCCACAAGCTCTGA PF02781 G6PD_C PF00479 G6PD_N function oxidoreductase activity function oxidoreductase activity, acting on CH-OH group of donors function oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor function glucose-6-phosphate 1-dehydrogenase activity function catalytic activity process metabolism process cellular metabolism process alcohol metabolism process monosaccharide metabolism process hexose metabolism process glucose metabolism process physiological process BE0001590 Glycine oxidase Bacillus subtilis (strain 168) # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Glycine oxidase Amino acid transport and metabolism This deaminating oxidase catalyzes the oxidation of sarcosine (N-methylglycine), N-ethylglycine and glycine. Lower activities on D-alanine, D-valine, and D-proline are detected. Does not act on L-amino acids and other D-amino acids thiO Cytoplasm (Probable) None 6.32 40937.0 Bacillus subtilis (strain 168) GenBank Gene Database Z99110 GenBank Protein Database 2633520 UniProtKB O31616 UniProt Accession GLOX_BACSU EC 1.4.3.19 >Glycine oxidase MKRHYEAVVIGGGIIGSAIAYYLAKENKNTALFESGTMGGRTTSAAAGMLGAHAECEERD AFFDFAMHSQRLYKGLGEELYALSGVDIRQHNGGMFKLAFSEEDVLQLRQMDDLDSVSWY SKEEVLEKEPYASGDIFGASFIQDDVHVEPYFVCKAYVKAAKMLGAEIFEHTPVLHVERD GEALFIKTPSGDVWANHVVVASGVWSGMFFKQLGLNNAFLPVKGECLSVWNDDIPLTKTL YHDHCYIVPRKSGRLVVGATMKPGDWSETPDLGGLESVMKKAKTMLPAIQNMKVDRFWAG LRPGTKDGKPYIGRHPEDSRILFAAGHFRNGILLAPATGALISDLIMNKEVNQDWLHAFR IDRKEAVQI >1110 bp ATGAAAAGGCATTATGAAGCAGTGGTGATTGGAGGCGGAATTATCGGTTCCGCAATTGCT TATTATTTGGCAAAGGAAAACAAAAACACCGCATTGTTTGAAAGCGGAACAATGGGCGGC AGAACGACAAGTGCCGCTGCCGGAATGCTGGGCGCCCATGCCGAATGCGAGGAACGTGAC GCGTTTTTTGATTTCGCTATGCACAGTCAGCGTCTGTACAAAGGTCTTGGAGAAGAGCTT TATGCATTATCCGGTGTGGATATCAGGCAGCATAACGGCGGTATGTTTAAGCTTGCATTT TCTGAAGAAGATGTGCTGCAGCTGAGACAGATGGACGATTTGGACTCTGTCAGCTGGTAT TCAAAAGAAGAGGTGTTAGAAAAAGAGCCGTATGCGTCTGGTGACATCTTTGGTGCATCT TTTATTCAGGATGATGTGCATGTGGAGCCTTATTTTGTTTGCAAGGCATATGTGAAAGCA GCAAAAATGCTTGGGGCGGAGATTTTTGAGCATACGCCCGTCCTGCATGTCGAACGTGAC GGTGAAGCCCTGTTCATCAAGACCCCTAGCGGAGACGTATGGGCTAATCATGTTGTCGTT GCCAGCGGGGTGTGGAGCGGAATGTTTTTTAAACAGCTTGGACTGAACAATGCTTTTCTC CCTGTAAAAGGGGAGTGCCTGTCCGTTTGGAATGATGATATCCCGCTGACAAAAACGCTT TACCATGATCACTGCTATATCGTACCGAGAAAAAGCGGAAGACTGGTTGTCGGCGCGACA ATGAAGCCGGGGGACTGGAGTGAAACACCGGATCTTGGCGGATTGGAATCTGTTATGAAA AAAGCAAAAACGATGCTGCCGGCTATACAGAATATGAAGGTGGATCGTTTTTGGGCGGGA CTCCGTCCGGGAACAAAGGATGGAAAACCGTACATCGGCAGACATCCTGAGGACAGCCGT ATTTTATTTGCGGCTGGCCATTTCAGAAACGGGATCCTGCTTGCTCCCGCAACGGGCGCT TTGATCAGTGATCTCATCATGAATAAAGAGGTCAACCAAGACTGGCTGCACGCATTCCGA ATTGATCGCAAGGAGGCGGTTCAGATATGA PF01266 DAO function catalytic activity function oxidoreductase activity process generation of precursor metabolites and energy process electron transport process physiological process process metabolism process cellular metabolism "
ns1:drugCategory	?:Keratolytic Agents
owl:sameAs	?:EXPT01629

"Hydroxyacetic Acid"

" 79-14-1 experimental David Y. Tang, Arthur M. Foster, "(3-Trifluoromethylphenyl)-alpha-hydroxyacetic acid and process for preparation." U.S. Patent US4296244, issued January, 1977. This compound belongs to the alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon. Alpha Hydroxy Acids and Derivatives Organic Compounds Organic Acids and Derivatives Hydroxy Acids and Derivatives Alpha Hydroxy Acids and Derivatives Primary Alcohols Polyamines Enolates Carboxylic Acids carboxylic acid derivative enolate carboxylic acid polyamine primary alcohol alcohol Hydroxyethanoic Acid Keratolytic Agents logP -1 ALOGPS logS 0.9 ALOGPS Water Solubility 6.08e+02 g/l ALOGPS logP -1 ChemAxon IUPAC Name 2-hydroxyacetic acid ChemAxon Traditional IUPAC Name hydroxyacetic acid ChemAxon Molecular Weight 76.0514 ChemAxon Monoisotopic Weight 76.016043994 ChemAxon SMILES OCC(O)=O ChemAxon Molecular Formula C2H4O3 ChemAxon InChI InChI=1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5) ChemAxon InChIKey InChIKey=AEMRFAOFKBGASW-UHFFFAOYSA-N ChemAxon Polar Surface Area (PSA) 57.53 ChemAxon Refractivity 14.35 ChemAxon Polarizability 6.2 ChemAxon Rotatable Bond Count 1 ChemAxon H Bond Acceptor Count 3 ChemAxon H Bond Donor Count 2 ChemAxon pKa (strongest acidic) 3.53 ChemAxon pKa (strongest basic) -3.6 ChemAxon Physiological Charge -1 ChemAxon Number of Rings 0 ChemAxon Bioavailability 1 ChemAxon Rule of Five true ChemAxon Melting Point 79.5 Â°C PhysProp logP -1.11 HANSCH,C ET AL. (1995) pKa 3.83 SERJEANT,EP & DEMPSEY,B (1979) ChEBI 29805 PubChem Compound 757 PubChem Substance 46508186 KEGG Compound C00160 PDB GOA BE0001089 Glucose-6-phosphate 1-dehydrogenase Human # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Glucose-6-phosphate 1-dehydrogenase Carbohydrate transport and metabolism Produces pentose sugars for nucleic acid synthesis and main producer of NADPH reducing power G6PD Xq28 None 6.84 59257.0 Human HUGO Gene Nomenclature Committee (HGNC) HGNC:4057 GenAtlas G6PD GeneCards G6PD GenBank Gene Database X03674 GenBank Protein Database 31543 UniProtKB P11413 UniProt Accession G6PD_HUMAN EC 1.1.1.49 G6PD >Glucose-6-phosphate 1-dehydrogenase MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGL LPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQR LNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSS DRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEP FGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQA NNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGK ALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESEL DLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPI PYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL >1548 bp ATGGCAGAGCAGGTGGCCCTGAGCCGGACCCACGTGTGCGGGATCCTGCGGGAAGAGCTT TTCCAGGGCGATGCCTTCCATCAGTCGGATACACACATATTCATCATCATGGGTGCATCG GGTGACCTGGCCAAGAAGAAGATCTACCCCACCATCTGGTGGCTGTTCCGGGATGGCCTT CTGCCCGAAAACACCTTCATCGTGGGCTATGCCCGTTCCCGCCTCACAGTGGCTGACATC CGCAAACAGAGTGAGCCCTTCTTCAAGGCCACCCCAGAGGAGAAGCTCAAGCTGGAGGAC TTCTTTGCCCGCAACTCCTATGTGGCTGGCCAGTACGATGATGCAGCCTCCTACCAGCGC CTCAACAGCCACATGAATGCCCTCCACCTGGGGTCACAGGCCAACCGCCTCTTCTACCTG GCCTTGCCCCCGACCGTCTACGAGGCCGTCACCAAGAACATTCACGAGTCCTGCATGAGC CAGATAGGCTGGAACCGCATCATCGTGGAGAAGCCCTTCGGGAGGGACCTGCAGAGCTCT GACCGGCTGTCCAACCACATCTCCTCCCTGTTCCGTGAGGACCAGATCTACCGCATCGAC CACTACCTGGGCAAGGAGATGGTGCAGAACCTCATGGTGCTGAGATTTGCCAACAGGATC TTCGGCCCCATCTGGAACCGGGACAACATCGCCTGCGTTATCCTCACCTTCAAGGAGCCC TTTGGCACTGAGGGTCGCGGGGGCTATTTCGATGAATTTGGGATCATCCGGGACGTGATG CAGAACCACCTACTGCAGATGCTGTGTCTGGTGGCCATGGAGAAGCCCGCCTCCACCAAC TCAGATGACGTCCGTGATGAGAAGGTCAAGGTGTTGAAATGCATCTCAGAGGTGCAGGCC AACAATGTGGTCCTGGGCCAGTACGTGGGGAACCCCGATGGAGAGGGCGAGGCCACCAAA GGGTACCTGGACGACCCCACGGTGCCCCGCGGGTCCACCACCGCCACTTTTGCAGCCGTC GTCCTCTATGTGGAGAATGAGAGGTGGGATGGGGTGCCCTTCATCCTGCGCTGCGGCAAG GCCCTGAACGAGCGCAAGGCCGAGGTGAGGCTGCAGTTCCATGATGTGGCCGGCGACATC TTCCACCAGCAGTGCAAGCGCAACGAGCTGGTGATCCGCGTGCAGCCCAACGAGGCCGTG TACACCAAGATGATGACCAAGAAGCCGGGCATGTTCTTCAACCCCGAGGAGTCGGAGCTG GACCTGACCTACGGCAACAGATACAAGAACGTGAAGCTCCCTGACGCCTACGAGCGCCTC ATCCTGGACGTCTTCTGCGGGAGCCAGATGCACTTCGTGCGCAGCGACGAGCTCCGTGAG GCCTGGCGTATTTTCACCCCACTGCTGCACCAGATTGAGCTGGAGAAGCCCAAGCCCATC CCCTATATTTATGGCAGCCGAGGCCCCACGGAGGCAGACGAGCTGATGAAGAGAGTGGGT TTCCAGTATGAGGGCACCTACAAGTGGGTGAACCCCCACAAGCTCTGA PF02781 G6PD_C PF00479 G6PD_N function oxidoreductase activity function oxidoreductase activity, acting on CH-OH group of donors function oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor function glucose-6-phosphate 1-dehydrogenase activity function catalytic activity process metabolism process cellular metabolism process alcohol metabolism process monosaccharide metabolism process hexose metabolism process glucose metabolism process physiological process BE0001590 Glycine oxidase Bacillus subtilis (strain 168) # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Glycine oxidase Amino acid transport and metabolism This deaminating oxidase catalyzes the oxidation of sarcosine (N-methylglycine), N-ethylglycine and glycine. Lower activities on D-alanine, D-valine, and D-proline are detected. Does not act on L-amino acids and other D-amino acids thiO Cytoplasm (Probable) None 6.32 40937.0 Bacillus subtilis (strain 168) GenBank Gene Database Z99110 GenBank Protein Database 2633520 UniProtKB O31616 UniProt Accession GLOX_BACSU EC 1.4.3.19 >Glycine oxidase MKRHYEAVVIGGGIIGSAIAYYLAKENKNTALFESGTMGGRTTSAAAGMLGAHAECEERD AFFDFAMHSQRLYKGLGEELYALSGVDIRQHNGGMFKLAFSEEDVLQLRQMDDLDSVSWY SKEEVLEKEPYASGDIFGASFIQDDVHVEPYFVCKAYVKAAKMLGAEIFEHTPVLHVERD GEALFIKTPSGDVWANHVVVASGVWSGMFFKQLGLNNAFLPVKGECLSVWNDDIPLTKTL YHDHCYIVPRKSGRLVVGATMKPGDWSETPDLGGLESVMKKAKTMLPAIQNMKVDRFWAG LRPGTKDGKPYIGRHPEDSRILFAAGHFRNGILLAPATGALISDLIMNKEVNQDWLHAFR IDRKEAVQI >1110 bp ATGAAAAGGCATTATGAAGCAGTGGTGATTGGAGGCGGAATTATCGGTTCCGCAATTGCT TATTATTTGGCAAAGGAAAACAAAAACACCGCATTGTTTGAAAGCGGAACAATGGGCGGC AGAACGACAAGTGCCGCTGCCGGAATGCTGGGCGCCCATGCCGAATGCGAGGAACGTGAC GCGTTTTTTGATTTCGCTATGCACAGTCAGCGTCTGTACAAAGGTCTTGGAGAAGAGCTT TATGCATTATCCGGTGTGGATATCAGGCAGCATAACGGCGGTATGTTTAAGCTTGCATTT TCTGAAGAAGATGTGCTGCAGCTGAGACAGATGGACGATTTGGACTCTGTCAGCTGGTAT TCAAAAGAAGAGGTGTTAGAAAAAGAGCCGTATGCGTCTGGTGACATCTTTGGTGCATCT TTTATTCAGGATGATGTGCATGTGGAGCCTTATTTTGTTTGCAAGGCATATGTGAAAGCA GCAAAAATGCTTGGGGCGGAGATTTTTGAGCATACGCCCGTCCTGCATGTCGAACGTGAC GGTGAAGCCCTGTTCATCAAGACCCCTAGCGGAGACGTATGGGCTAATCATGTTGTCGTT GCCAGCGGGGTGTGGAGCGGAATGTTTTTTAAACAGCTTGGACTGAACAATGCTTTTCTC CCTGTAAAAGGGGAGTGCCTGTCCGTTTGGAATGATGATATCCCGCTGACAAAAACGCTT TACCATGATCACTGCTATATCGTACCGAGAAAAAGCGGAAGACTGGTTGTCGGCGCGACA ATGAAGCCGGGGGACTGGAGTGAAACACCGGATCTTGGCGGATTGGAATCTGTTATGAAA AAAGCAAAAACGATGCTGCCGGCTATACAGAATATGAAGGTGGATCGTTTTTGGGCGGGA CTCCGTCCGGGAACAAAGGATGGAAAACCGTACATCGGCAGACATCCTGAGGACAGCCGT ATTTTATTTGCGGCTGGCCATTTCAGAAACGGGATCCTGCTTGCTCCCGCAACGGGCGCT TTGATCAGTGATCTCATCATGAATAAAGAGGTCAACCAAGACTGGCTGCACGCATTCCGA ATTGATCGCAAGGAGGCGGTTCAGATATGA PF01266 DAO function catalytic activity function oxidoreductase activity process generation of precursor metabolites and energy process electron transport process physiological process process metabolism process cellular metabolism "

owl:sameAs

?:EXPT01629

Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB03085"

Context graph